Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Prospective, Open-label, Single-arm Clinical Trial to Evaluate the Efficacy of Faricimab and Biomarker Assessment in Patients With Neovascular Age-related Macular Degeneration

NCT07367282 is registered in ClinicalTrials.gov with Junyeop Lee as lead sponsor.

NCT NCT07367282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07367282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Prospective, Open-label, Single-arm Clinical Trial to Evaluate the Efficacy of Faricimab and Biomarker Assessment in Patients With Neovascular Age-related Macular Degeneration
Lead sponsor
Junyeop Lee
Phase
Phase 4
Overall status
Recruiting
Start date
June 29, 2026
Completion date
December 31, 2028
Enrollment
64 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration